In human immunodeficiency virus type 1-infected cells, the efficient expression of viral proteins from unspliced and singly spliced RNAs is dependent on two factors: the presence in the cell of the viral protein Rev and the presence in the viral RNA of the Rev-responsive element (RRE). We show here that the HIV-1 Rev/RRE system can increase the expression of avian leukosis virus (ALV) Retroviruses can be classified as either simple or complex, on the basis of their genomic organization (1-3). Avian leukosis virus (ALV) is a simple retrovirus. The ALV genome contains gag,pol, and env genes that encode the viral structural proteins, the enzymes required for viral replication and the surface glycoproteins, respectively (4). Complex retroviruses, such as human immunodeficiency virus type 1 (HIV-1), have, in addition to the gag, pol, and env genes, regulatory and accessory genes that are expressed from subgenomic messages that have undergone multiple splicing reactions (5-8).
these cells. In this system, the Rev/RRE interaction appears to facilitate the export of full-length unspliced ALV RNA from the nucleus to the cytoplasm, allowing increased production of the ALV structural proteins. Gag protein is produced in the cytoplasm of the ALV-transfected cells even in the absence of a Rev/RRE interaction. However, a functional Rev/RRE interaction increases the amount of Gag present intracellularly and, more strikingly, results in the release of mature ALV particles into the supernatant. RCAS virus containing an RRE is replication-competent in chicken embryo fibroblasts; however, we have been unable to determine whether the particles produced in D-17 cells are as infectious as the particles produced in chicken embryo fibroblasts.
Retroviruses can be classified as either simple or complex, on the basis of their genomic organization (1-3). Avian leukosis virus (ALV) is a simple retrovirus. The ALV genome contains gag,pol, and env genes that encode the viral structural proteins, the enzymes required for viral replication and the surface glycoproteins, respectively (4). Complex retroviruses, such as human immunodeficiency virus type 1 (HIV-1), have, in addition to the gag, pol, and env genes, regulatory and accessory genes that are expressed from subgenomic messages that have undergone multiple splicing reactions (5-8).
Retroviruses are (+)-strand viruses; i.e., their genomes are the same polarity as their mRNAs (9) . In most retroviruses, including ALV and HIV-1, a single RNA transcript serves as the genome for the progeny virus, as one of the viral messages, and as the precursor for all of the spliced subgenomic messages. The retroviral life cycle is absolutely dependent on the appropriate regulation of splicing and the efficient transport and translation of both spliced and unspliced versions of viral RNA.
For ALV, we do not understand what controls either the ratio of spliced to unspliced RNA or the mechanisms involved in transporting the unspliced RNA from the nucleus to the cytoplasm. An element known as the negative regulator of splicing, located in the gag region of ALV, may be involved (10, 11) and other cis-acting sequences have been identified throughout the genome (12, 13) . In the complex retroviruses,
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RNA splicing patterns and the transport of unspliced RNAs appear to be controlled by viral regulatory proteins (14-21). In HIV-1, the interaction of the viral protein Rev with the Rev-responsive element (RRE) allows unspliced and intermediate spliced messages to be transported and translated efficiently. It has been proposed that this interaction (22-25) affects message transport and translation at many steps, including message stability (26, 27), commitment to splicing (28, 29), nuclear/cytoplasmic transport (26, (30) (31) (32) , RNA/ poly(A)+-binding protein interactions (33), and translatability (34-36). These different activities may, at least in part, reflect the different cell types and systems that have been used to study the Rev/RRE interactions.
In contrast to avian cells, mammalian cells do not support the replication of ALV (37-39). When a wild-type ALV is experimentally introduced into mammalian cells, low levels of Gag protein are produced (40, 41), but no infectious virus is released from the cells (37, 42) . Defects in either splicing, transport, or stability of full-length ALV RNA could help to explain the low levels of ALV Gag and lack of ALV particles produced by mammalian cells. We have asked how the HIV-1 Rev/RRE system affects ALV production in a mammalian cell line.
MATERIALS AND METHODS
Plasmids, Cells, and Transfection. D-17 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and antibiotics. We routinely used 5 ,ug of RCAS-based plasmids, 2 ,ug of pCMV-rev (43) (when indicated), and 0.25 jig of pRSVluc (44) per dish. Transfection was by the calcium phosphate method (45). Cells and supernatants were harvested 24 hr after addition of DNA. Three plates were transfected for each data point. The supernatants from all three plates were pooled, cleared by centrifugation at 1000 x g for 10 min, and frozen at -70°C for later analysis. Cells from individual plates were harvested for the analysis of cell-associated proteins, total RNA, and cytoplasmic and nuclear RNA. (49) (Fig. 1 ). These two viruses differ in the source of the pol gene that they carry: RCAS has the pol gene from the Schmidt-Ruppin A strain and RCASBP contains the pol gene from the Bryan high-titer strain of RSV. In avian cells, RCASBP replicates to a higher titer than RCAS (51). We were curious to see whether the Bryan pol region would have an effect on the level of ALV protein expressed in mammalian cells.
Transfection of plasmids containing full-length infectious proviruses into chicken embryo fibroblasts (CEFs) resulted, in all cases, in the production of infectious virus (data not shown). Analysis of viral particle production by Western blot showed identical patterns of processing of the Gag polyprotein in the parental viruses and the viruses containing an RRE. However, the viruses containing an RRE grew more slowly than the parental viruses and lost their RRE sequences upon continued passage of the virus on CEFs.
The same plasmids were then transfected into the D-17 canine cell line. We chose this cell line because it can be transfected efficiently and the RSV LTR is a strong promoter in these cells (A. Zolotukhin, personal communication) . Western blots of lysates from transfected D-17 cells showed that all of the viral DNAs directed the expression of cell-associated Gag polyprotein ( Fig. 2A) . However, cells that were transfected with a Rev-producing plasmid and one of the RREcontaining viruses contained significantly higher levels of Gag. The presence of Rev had a similar effect on both the RCAS/ RRE and RCASBP/RRE viruses. For both of these viruses the amount of Gag in the cells was increased by the interaction of Rev and the RRE and processing of the Gag polyprotein was seen only when both Rev and the RRE were present. The RCASBP pol region did not appear to have any effect on the expression of ALV Gag proteins in these cells in either the presence or the absence of Rev.
When the viral genome did not contain an RRE, Rev decreased Gag production by a factor of 3-5. This inhibition appears to be a nonspecific effect of Rev on cotransfected plasmids that do not contain an RRE (50). In all experiments, the plasmid pRSVluc was cotransfected and luciferase activity was measured to determine the relative transfection efficiencies. Cotransfection with Rev consistently decreased luciferase expression (Fig. 2B) . The decrease in luciferase activity was similar to the effect of Rev on the expression of viral protein from RCAS and RCASBP without an RRE.
Western blot analysis of particles harvested from the supernatant of D-17 cells 24 hr posttransfection showed that one effect of the Rev/RRE interaction was to permit the release of ALV particles into the supernatant (Fig. 2C) . Particle production occurred only when an RRE-containing virus was introduced into cells that simultaneously expressed Rev. Processing of Gag in these particles was indistinguishable from that seen in ALV particles produced in CEFs.
To investigate which step of ALV expression was affected by the Rev/RRE interaction, we performed Northern blot analysis of total, nuclear, and cytoplasmic RNAs. In total and nuclear RNA preparations ( Fig. 3A and B (Fig. 3C) . These findings suggest that in this system the Rev/RRE interaction does not stabilize the unspliced viral message but instead plays a role in transport and/or compartmentalization (and possibly translation) of the full-length viral mRNAs.
We wanted to determine whether the processed Gag protein detected in the supernatant represented authentic viral particles. Northern analysis showed that the particles contained full-length ALV RNA (data not shown), as would be expected for authentic ALV particles. Electron micrographs of the ALV particles produced in D-17 cells (Fig. 4) show that the particles have condensed cores as seen in mature ALV particles produced from CEFs (not shown). Most D-17 cells, there appears to be a block to the efficient export of full-length viral RNA from the nucleus to the cytoplasm. In the absence of Rev/RRE a moderate amount of Gag was present in the cytoplasm; however, the Gag that was produced in the absence of a Rev/RRE interaction did not assemble into viral particles, as judged by the lack of Gag proteins in the supernatant, lack of appropriate cleavage of the Gag precursor into mature Gag proteins, and our inability to find viral particles by electron microscopy. One possibility is that the Rev/RRE mediated particle release we observed was simply a result of mass action (i.e., there is a threshold level of Gag required for particle assembly to occur). We consider this explanation unlikely, as the difference in the amount of Gag produced in the presence or absence of Rev is not large. An alternative explanation is that differential splicing may be involved. For example, it is possible that, in the absence of a Rev/RRE interaction, alternative splicing results in what appears to be unspliced RNA yet codes for a defective Gag polyprotein that inhibits particle assembly. A third possibility is that the Rev/RRE interaction facilitates the transport of viral RNAs to a specific cellular compartment that somehow promotes particle assembly.
(ii) Although the overall levels of viral RNA were lower in the ALV-transfected D-17 cells than in ALV-infected CEFs, the ratio of spliced to unspliced RNA in the total RNA pool of the transfected D-17 cells was not significantly different from that seen in ALV-infected chicken cells. In contrast, previous studies on the expression of RSV in NIH 3T3 mouse cells transformed with RSV showed that the majority of viral RNA was present as the spliced src. message (58, 59). However, since these cells had been selected for high levels of Src expression, it was possible that the pattern of RNA splicing seen in the RSV-transformed cells was a result of that selection. In NIH 3T3 cells transiently transfected with RSV the results were only slightly different (60). Multiple spliced forms of RNA were seen, including some spliced forms not seen in ALV-infected chicken cells. The majority of the RSV RNA was either the src-spliced message, or a doubly spliced env/src fusion transcript. In the ALV-transfected D-17 cells we found that the overall pattern of viral RNA was very similar to that seen in ALV-infected chicken cells. However, most of the full-length ALV RNA in D-17 cells was found in the nucleus; the ALV RNA present in the cytoplasm of D-17 cells was almost entirely env-spliced RNA. The lack of full-length viral RNA in the cytoplasm did not appear to be due to the instability of the unspliced viral RNA but rather to a block in its transport from the nucleus. It has been suggested that the association of unspliced RNA with nuclear splicing factors could inhibit the transport of intron-containing RNAs from the nucleus to the cytoplasm (12, 28 (iv) One major difference between avian and mammalian retroviruses is that the Gag protein of mammalian retroviruses is obligately myristoylated on its N terminus (64, 65) , whereas the ALV Gag protein is acetylated (66) . N-terminal myristoylation of ALV Gag has been reported to promote ALV particle formation in certain mammalian cells (67) (68) (69) . However, a more recent report (70) has shown that myristoylation of Gag is not required for assembly of ALV particles in mammalian cells. Since none of the vectors used in these experiments encoded signals for myristoylation of the Gag precursor protein, our studies confirm that myristoylation of the ALV Gag precursors is not an important determinant of ALV virion assembly in mammalian cells.
We were surprised to observe cell-associated processing of the Gag precursor in D-17 cells. Ordinarily, activation of the viral protease and particle maturation are tightly linked to budding of the viral particle from the cell surface. Cellassociated processing of Gag is not usually seen in ALVinfected CEFs but has been reported when ALV is expressed in other host systems, including turkey cells and several mammalian cell lines, especially when high levels of the Gag protein are produced. One possibility is that the processed proteins we observed were associated with mature viral particles that had been partially or completely extruded through the cell membrane and remained associated with the membrane in these cells. Alternatively, particles may have been extruded into deep pits in the cell membrane or into vesicles within the cell. The electron micrographs of the transfected D-17 cells suggest that such events do occur. We observed several cases in which mature membrane-bound particles were present in vesicles or pits (Fig. 5) .
In most eukaryotic cells, there is a block to the export of unspliced or partially spliced RNAs from the nucleus to the cytoplasm (26, 61). Different retroviruses have found different solutions to this restriction. Lentiviruses and other complex retroviruses express a viral protein and encode a cis-acting RNA sequence to allow the efficient transport and translation of their unspliced and intermediate spliced 19) . Type D simple retroviruses (71) have been shown to contain a cis-acting RNA element (designated the constitutive transport element, or CTE) that apparently provides an RRE-like function via interaction with cellular "Rev-like" factor(s) (72, 73) .
The regulation of RNA transport and translation in ALV is cell-type dependent. The mammalian counterparts of the factor(s) that provide these functions in avian cells are unable to appropriately regulate ALV RNA, either because they are not present in mammalian cells or because they do not recognize the cognate signals in the ALV RNA. We have shown that the HIV-1 Rev/RRE interaction can promote ALV particle production in mammalian cells and that the Rev/RRE interaction is sufficient to cause the efficient transMicrobiology: Nasioulas et al. 11944 Microbiology: Nasioulas et al.
port and translation of unspliced RNA in mammalian cells that is essential for ALV particle production. These data demonstrate that ALV replication is dependent on appropriate posttranscriptional RNA regulation for virus production. The HIV-1 Rev/RRE system, which can act in a variety of cells and in heterologous RNAs (74), can rescue ALV production in mammalian cells. We believe that ALV and other simple retroviruses, will, like the type D retroviruses, be found to depend on cellular factors for appropriate posttranscriptional regulation of RNA. In contrast, the complex retroviruses appear to have acquired, presumably from their cellular hosts, the factors necessary to control these processes in a cellindependent manner.
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